| 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents B Pajak, E Siwiak, M Sołtyka, A Priebe, R Zieliński, I Fokt, M Ziemniak, ... International journal of molecular sciences 21 (1), 234, 2019 | 353 | 2019 |
| Epigenetic reprogramming of cancer-associated fibroblasts deregulates glucose metabolism and facilitates progression of breast cancer LM Becker, JT O’Connell, AP Vo, MP Cain, D Tampe, L Bizarro, ... Cell reports 31 (9), 2020 | 172 | 2020 |
| Targeted drug delivery and image-guided therapy of heterogeneous ovarian cancer using HER2-targeted theranostic nanoparticles M Satpathy, L Wang, RJ Zielinski, W Qian, YA Wang, AM Mohs, ... Theranostics 9 (3), 778, 2019 | 96 | 2019 |
| SimBoolNet—a Cytoscape plugin for dynamic simulation of signaling networks J Zheng, D Zhang, PF Przytycki, R Zielinski, J Capala, TM Przytycka Bioinformatics 26 (1), 141-142, 2010 | 79 | 2010 |
| Active targeting using her‐2‐affibody‐conjugated nanoparticles enabled sensitive and specific imaging of orthotopic her‐2 positive ovarian tumors M Satpathy, L Wang, R Zielinski, W Qian, M Lipowska, J Capala, GY Lee, ... Small 10 (3), 544-555, 2014 | 78 | 2014 |
| The crosstalk between EGF, IGF, and Insulin cell signaling pathways-computational and experimental analysis R Zielinski, PF Przytycki, J Zheng, D Zhang, TM Przytycka, J Capala BMC systems biology 3, 1-10, 2009 | 77 | 2009 |
| Affitoxin—a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors R Zielinski, I Lyakhov, A Jacobs, O Chertov, G Kramer-Marek, N Francella, ... Journal of Immunotherapy 32 (8), 817-825, 2009 | 75 | 2009 |
| HER2-affitoxin: a potent therapeutic agent for the treatment of HER2-overexpressing tumors R Zielinski, I Lyakhov, M Hassan, M Kuban, K Shafer-Weaver, ... Clinical Cancer Research 17 (15), 5071-5081, 2011 | 58 | 2011 |
| HER2‐and EGFR‐specific affiprobes: Novel recombinant optical probes for cell imaging I Lyakhov, R Zielinski, M Kuban, G Kramer‐Marek, R Fisher, O Chertov, ... Chembiochem 11 (3), 345-350, 2010 | 58 | 2010 |
| An enolase inhibitor for the targeted treatment of ENO1-deleted cancers YH Lin, N Satani, N Hammoudi, VC Yan, Y Barekatain, S Khadka, ... Nature metabolism 2 (12), 1413-1426, 2020 | 48 | 2020 |
| Radiation with STAT3 blockade triggers dendritic cell–T cell interactions in the glioma microenvironment and therapeutic efficacy M Ott, C Kassab, A Marisetty, Y Hashimoto, J Wei, D Zamler, JS Leu, ... Clinical Cancer Research 26 (18), 4983-4994, 2020 | 48 | 2020 |
| Potential of PET to predict the response to trastuzumab treatment in an ErbB2-positive human xenograft tumor model G Kramer-Marek, M Gijsen, DO Kiesewetter, R Bennett, I Roxanis, ... Journal of Nuclear Medicine 53 (4), 629-637, 2012 | 48 | 2012 |
| In vivo fluorescence lifetime imaging monitors binding of specific probes to cancer biomarkers Y Ardeshirpour, V Chernomordik, R Zielinski, J Capala, G Griffiths, ... PloS one 7 (2), e31881, 2012 | 48 | 2012 |
| PET of HER2-positive pulmonary metastases with 18F-ZHER2: 342 affibody in a murine model of breast cancer: comparison with 18F-FDG G Kramer-Marek, M Bernardo, DO Kiesewetter, U Bagci, M Kuban, ... Journal of Nuclear Medicine 53 (6), 939-946, 2012 | 45 | 2012 |
| Quantitative analysis of Her2 receptor expression in vivo by near-infrared optical imaging V Chernomordik, M Hassan, SB Lee, R Zielinski, A Gandjbakhche, ... Molecular imaging 9 (4), 7290.2010. 00018, 2010 | 44 | 2010 |
| Classical versus custom orbital wall reconstruction: Selected factors regarding surgery and hospitalization R Zieliński, M Malińska, M Kozakiewicz Journal of Cranio-Maxillofacial Surgery 45 (5), 710-715, 2017 | 43 | 2017 |
| Yeast holoenzyme of protein kinase CK2 requires both β and β′ regulatory subunits for its activity K Kubiński, K Domańska, E Sajnaga, E Mazur, R Zieliński, R Szyszka Molecular and cellular biochemistry 295, 229-236, 2007 | 37 | 2007 |
| In vivo fluorescence lifetime imaging for monitoring the efficacy of the cancer treatment Y Ardeshirpour, V Chernomordik, M Hassan, R Zielinski, J Capala, ... Clinical Cancer Research 20 (13), 3531-3539, 2014 | 33 | 2014 |
| Two different techniques of manufacturing TMJ replacements–a technical report M Kozakiewicz, T Wach, P Szymor, R Zieliński Journal of Cranio-Maxillofacial Surgery 45 (9), 1432-1437, 2017 | 32 | 2017 |
| Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox … RJ Zielinski, JV Smedley, PY Perera, PM Silvera, TA Waldmann, J Capala, ... Vaccine 28 (43), 7081-7091, 2010 | 27 | 2010 |
